Claim Missing Document
Check
Articles

Found 2 Documents
Search

Uji Mutu Fisik Dan Stabilitas Body Scrub Ekstrak Biji Kopi Robusta (Coffea Canephora) Suzalin, Ferawati; Rahmania, Dhea; Wilsya, Mayaranti
Jurnal Kesehatan Farmasi Vol 5 No 2 (2023)
Publisher : Jurusan Farmasi, Poltekkes Kemenkes Palembang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36086/jkpharm.v5i2.2062

Abstract

Kopi robusta (Coffea canephora) telah banyak dimanfaatkan oleh masyarakat khususnya Sumatera Selatan sebagai bahan pangan, obat tradisional, dan kosmetika. Kopi robusta memiliki senyawa metabolit yang memiliki peran sebagai antioksidan dan sebagai pelembab kulit. Penelitian ini bertujuan untuk mengetahui Formulasi yang baik untuk membuat Body Scrub dari Ekstrak Biji Kopi Robusta (Coffea canephora) yang telah memenuhi syarat uji mutu fisik dan stabilitas sesuai dengan standar. Metode yang digunakan dalam penelitian ini yaitu Metode Eksperimental. Hasil dari penelitian akan dilakukan pengujian meliputi Uji organoleptik, Uji homogenitas, Uji daya sebar, Uji Daya Lekat, Uji jenis emulsi, Uji pH, Uji Stabilitas, dan Uji Hedonik. Hasil dari Uji Organoleptik menunjukkan bahwa masing-masing formula tidak mengalami perubahan warna, aroma dan tekstur. Hasil dari Uji Homogenitas menunjukkan tidak terlihat adanya gumpalan dan warna pada sediaan yang merata. Hasil Uji Daya Sebar menunjukkan bahwa daya sebar yang baik ada pada Formulasi III yaitu 5,1 cm. Hasil Uji Daya Lekat menunjukkan semua formulasi memenuhi syarat daya lekat yang baik. Hasil Uji Jenis Emulsi menunjukkan bahwa sediaan ini termasuk dalam Jenis emulsi Minyak dalam Air (O/W). Hasil Uji pH menunjukkan semua formula masuk dalam persyaratan Uji pH yang baik. Uji Stabilitas menunjukkan seluruh formulasi stabil dalam suhu 4°C and 40°C. Uji Hedonik menunjukkan hasil bahwa Formula III paling banyak disukai panelis. Formulasi sediaan Body Scrub Ekstrak Biji Kopi Robusta (Coffea canephora) telah memenuhi karakteristik uji Mutu Fisik Body Scrub dan Stabilitas yang meliputi Uji Organoleptik, Uji Homogenitas, Uji Daya Sebar, Uji Daya Lekat, Uji Jenis Emulsi, Uji pH, Uji Stabilitas sediaan Body Scrub, dan Uji Hedonik.
Oral Insulin Nanoparticles in Animal Models of Diabetes: A Systematic Review of Recent Studies Rahmania, Dhea; Shiyan, Shaum; Kusnadi, Yulianto; Subandrate, Subandrate; Palungan, Juliana; Rosdah, Ayeshah Augusta
Pharmaceutical Sciences and Research Vol. 13, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Oral insulin has long been explored as a potential alternative to injectable insulin therapy. However, the development remains challenging due to enzymatic degradation in the gastrointestinal tract and limited intestinal absorption. Nanoparticle-based delivery systems have also been proposed as a strategy to protect insulin and improve uptake after oral administration. Therefore, this systematic review aimed to summarize recent preclinical studies investigating oral insulin nanoparticles in diabetic animal models and examine the reported pharmacological outcomes. Relevant studies were identified through database searches in PubMed, SpringerLink, and ScienceDirect using predefined keywords related to oral insulin, nanoparticles, diabetes, and animal models. Articles published between January 2021 and 2026 were screened following the predefined eligibility criteria. After removal of duplicates and records that did not meet accessibility requirements, titles and abstracts were reviewed, followed by full-text evaluation of potentially relevant studies. Non-English articles, studies without accessible full text, and analyses where insulin was not the primary intervention were excluded. A total of 16 studies met the inclusion criteria and were included in the narrative synthesis. The results showed that most investigations focused on polymer-based nanoparticles, but silica-based, biomimetic, and hybrid systems were also reported. Across studies, oral insulin nanoparticles reduced blood glucose levels in diabetic animals. The magnitude, onset, and duration of the glycemic response varied considerably among formulations. Current evidence suggested that oral insulin nanoparticles could produce pronounced glucose-lowering effects with rapid onset and sustained activity, depending on the formulation. Further standardized pharmacological evaluations in animal models were needed to assess translational potential for human application.